Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fuling Zhou

Showing results (181-190 of 223) with videos related to

Pageof 23
Sort By:
Precision Clinical Medicine|August 12, 2022
Personnel protection strategy for healthcare workers in Wuhan during the COVID-19 epidemicFan Fan Hou, Fuling Zhou, Xin Xu, et al.
Free Radical Biology & Medicine|November 16, 2019
The novel thioredoxin reductase inhibitor A-Z2 triggers intrinsic apoptosis and shows efficacy in the treatment of acute myeloid leukemiaDongdong Zhang, Yujiao Liu, Ziyi Luo, et al.
Haematologica|January 11, 2020
WEE1 inhibition induces glutamine addiction in T-cell acute lymphoblastic leukemiaJuncheng Hu, Tianci Wang, Jin Xu, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 21, 2018
Compound kushen injection suppresses human acute myeloid leukaemia by regulating the Prdxs/ROS/Trx1 signalling pathwayYanxia Jin, Qian Yang, Li Liang, et al.
Iscience|April 25, 2025
Erratum: JUN mediates glucocorticoid resistance by stabilizing HIF1a in T cell acute lymphoblastic leukemiaZhijie Zhang, Jiangzhou Shi, Qifang Wu, et al.
Cell Reports. Medicine|October 7, 2022
Space-time-regulated imaging analyzer for smart coagulation diagnosisLongfei Chen, Le Yu, Yantong Liu, et al.
Journal of Biophotonics|March 1, 2025
High-Throughput and Stain-Free Morphological Analysis of Sperm Using Optofluidic Time-Stretch Imaging Flow CytometryYueyun Weng, Yujie Zou, Yan Jin, et al.
Iscience|November 29, 2023
JUN mediates glucocorticoid resistance by stabilizing HIF1a in T cell acute lymphoblastic leukemiaZhijie Zhang, Jiangzhou Shi, Qifang Wu, et al.
Haematologica|June 12, 2025
Atypical acute promyelocytic leukemia with tripartite fusion gene <i>PML::RARG::LINE-L2a</i> is resistant to ATRA but sensitive to arsenic-based therapySanyun Wu, Yalan Yu, Xiang Lin, et al.
Eclinicalmedicine|September 21, 2020
Tracing asymptomatic SARS-CoV-2 carriers among 3674 hospital staff:a cross-sectional surveyFuling Zhou, Jingfeng Li, Mengxin Lu, et al.
Pageof 23

Showing results (181-190 of 223) with videos related to

Sort By:
Pageof 23
Precision Clinical Medicine|August 12, 2022
Personnel protection strategy for healthcare workers in Wuhan during the COVID-19 epidemicFan Fan Hou, Fuling Zhou, Xin Xu, et al.
Free Radical Biology & Medicine|November 16, 2019
The novel thioredoxin reductase inhibitor A-Z2 triggers intrinsic apoptosis and shows efficacy in the treatment of acute myeloid leukemiaDongdong Zhang, Yujiao Liu, Ziyi Luo, et al.
Haematologica|January 11, 2020
WEE1 inhibition induces glutamine addiction in T-cell acute lymphoblastic leukemiaJuncheng Hu, Tianci Wang, Jin Xu, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 21, 2018
Compound kushen injection suppresses human acute myeloid leukaemia by regulating the Prdxs/ROS/Trx1 signalling pathwayYanxia Jin, Qian Yang, Li Liang, et al.
Iscience|April 25, 2025
Erratum: JUN mediates glucocorticoid resistance by stabilizing HIF1a in T cell acute lymphoblastic leukemiaZhijie Zhang, Jiangzhou Shi, Qifang Wu, et al.
Cell Reports. Medicine|October 7, 2022
Space-time-regulated imaging analyzer for smart coagulation diagnosisLongfei Chen, Le Yu, Yantong Liu, et al.
Journal of Biophotonics|March 1, 2025
High-Throughput and Stain-Free Morphological Analysis of Sperm Using Optofluidic Time-Stretch Imaging Flow CytometryYueyun Weng, Yujie Zou, Yan Jin, et al.
Iscience|November 29, 2023
JUN mediates glucocorticoid resistance by stabilizing HIF1a in T cell acute lymphoblastic leukemiaZhijie Zhang, Jiangzhou Shi, Qifang Wu, et al.
Haematologica|June 12, 2025
Atypical acute promyelocytic leukemia with tripartite fusion gene <i>PML::RARG::LINE-L2a</i> is resistant to ATRA but sensitive to arsenic-based therapySanyun Wu, Yalan Yu, Xiang Lin, et al.
Eclinicalmedicine|September 21, 2020
Tracing asymptomatic SARS-CoV-2 carriers among 3674 hospital staff:a cross-sectional surveyFuling Zhou, Jingfeng Li, Mengxin Lu, et al.
Pageof 23